FDA Section 4 \u2022 who must NOT take this

Escitalopram oxalate - Contraindications

These conditions, allergies, and situations mean Escitalopram oxalate should NOT be used. From the US FDA-approved drug label Section 4.

4 CONTRAINDICATIONS Serotonin Syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with escitalopram tablets or within 14 days of stopping treatment with escitalopram tablets.

Do not use escitalopram tablets within 14 days of stopping an MAOI intended to treat psychiatric disorders.

In addition, do not start escitalopram tablets in a patient who is being treated with linezolid or intravenous methylene blue .

Pimozide: Do not use concomitantly .

Known hypersensitivity to escitalopram or citalopram or any of the inactive ingredients .

4.1 Monoamine Oxidase Inhibitors (MAOIs) The use of MAOIs intended to treat psychiatric disorders with escitalopram tablets or within 14 days of stopping treatment with escitalopram tablets are contraindicated because of an increased risk of serotonin syndrome.

The use of escitalopram tablets within 14 days of stopping an MAOI intended to treat psychiatric disorders are also contraindicated [see Dosage and Administration , and Warnings and Precautions ] .

Starting escitalopram tablets in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome [see Dosage and Administration , and Warnings and Precautions ] .

4.2 Pimozide Concomitant use in patients taking pimozide is contraindicated [see Drug Interactions ] .

4.3 Hypersensitivity to escitalopram or citalopram Escitalopram tablets are contraindicated in patients with a hypersensitivity to escitalopram or citalopram or any of the inactive ingredients in escitalopram tablets.

Does any of this apply to YOU?

Ask Health AI \u2192